Threat Or Opportunity? How Trump's Generic Drug Tariff Plan Could Impact Indian Pharma Stocks

Trump's proposed tariff plan gives generic drugmakers a two-year window before duties kick in. Here's how it could impact Indian pharma companies from Sun Pharma to Dr. Reddy's.
Key takeaways
- Category: Stocks.
Why it matters
A routine update. Use the price and stock snapshot to gauge how the market is responding.










